![Jared Gollob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jared Gollob
Teknisk/Vetenskaplig/F&U Direktör på
KYMERA THERAPEUTICS, INC.
Förmögenhet: 6 M $ per 2026-05-31
Profil
Jared Gollob is Chief Medical Officer at Kymera Therapeutics, Inc. since 2018.
Formerly, Dr. Gollob was Director of the Biologic Therapy Program at Duke University from 2002 to 2007.
From 2012 to 2018, Dr. Gollob was Global VP of Medical Affairs & Clinical Development at Alnylam Pharmaceuticals, Inc. Education includes undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-31 | 71 359 ( 0,09 % ) | 6 M $ | 2026-05-31 |
Aktiva positioner av Jared Gollob
| Företag | Position | Start |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-09-01 |
Tidigare kända positioner av Jared Gollob
| Företag | Position | Slut |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-08-01 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2007-09-01 |
Jared Gollobs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
88
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
